Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Slate Path Capital LP
10% owner at Cyclerion Therapeutics. Filing since 3 Jun 2021.
CIK 0001559706
Company
Date
Role
Action
Shares
Amount
Of holding
CYCN
Cyclerion Therapeutics, Inc.
21 Nov 2024
10% owner
Sold at will
357,880
$555.11K
100%
CYCN
Cyclerion Therapeutics, Inc.
3 Jun 2021
10% owner
Bought
961,538
$3.00M
15.5%
2 decisions on file.
